• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Does Concerta augmentation of antidepressants work?

Does Concerta augmentation of antidepressants work?

March 1, 2008
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
S. Nassir Ghaemi, MD

Psychostimulants are commonly added to antidepressants in order to augment their effects, but most of the clinical trials have been either open or small controlled trials. In what may be the largest trial done to date, these investigators (who received funding from Janssen-Ortho, the maker of Concerta) randomized 145 depressed patients, all of whom had failed at least one trial of an antidepressant, to either Concerta augmentation (n = 73) or placebo augmentation (n = 72). Concerta was started at 18 mg/day and was gradually increased, as needed, up to a maximum of 54 mg/day; the average final dose was 36.4 mg/day. The primary outcome measure was the MADRS depression scale score after 5 weeks. Results: There was no difference between Concerta and placebo on the MADRS scale, nor on any of the secondary outcome scales except for the Apathy Evaluation Scale, which showed a small improvement in favor of Concerta. Concerta also outperformed placebo on measures of fatigue early on, but at the 5 week endpoint, there was no significant benefit (Ravindran AV et al., J Clin Psychiatry 2008;69:87-94).

TCPR’s Take: Similar to earlier placebo- controlled trials of Provigil augmentation, it appears that Concerta augmentation doesn’t have an effect on the core symptoms of depression, but is somewhat helpful for apathy and fatigue. Whether this benefit is sufficient to outweigh the disadvantages of prescribing a stimulant (mild increase in heart rate and blood pressure, the hassles of prescribing a scheduled substance) is a judgement call for each clinician and each patient.

General Psychiatry
KEYWORDS antidepressants
    www.thecarlatreport.com
    Issue Date: March 1, 2008
    SUBSCRIBE NOW
    Table Of Contents
    Smoking Cessation: Which Options are Best?
    Practical Advice on Treating Alcohol Problems
    Behavior Therapy for Substance Abuse
    Does Concerta augmentation of antidepressants work?
    Twice the risk of suicide when taking antiepileptics
    Medications for Alcohol Dependence
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.